Article
Mutant N-RAS induces erythroid lineage dysplasia in human CD34+ cells.
The Journal of experimental medicine - 7 Apr 1997
Darley R L, Hoy T G, Baines P, Padua R A, Burnett A K
Abstract excerpt
RAS mutations arise at high frequency (20-40%) in both acute myeloid leukemia and myelodysplastic syndrome (which is considered to be a manifestation of preleukemic disease). In each case, mutations arise predominantly at the N-RAS locus. These observations suggest a fundamental role for this oncogene in leukemogenesis. However, despite its obvious significance, little is known of how this key oncogene may...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
